Status:
COMPLETED
Analgesia Management in Bariatric Surgery
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Morbid Obesity
Bariatric Surgery Candidate
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Following laparoscopic bariatric surgery, multimodal analgesia is recommended to avoid the adverse effects of opioids by reducing their use. Although lidocaine, ketamine, and dexmedetomidine have been...
Detailed Description
Patients will be divided into three groups. Group L: The patients will receive intravenous lidocaine (2 mg/kg/h) immediately after anesthesia induction. At the end of the surgery, the dose will be de...
Eligibility Criteria
Inclusion
- Body mass index\>35 kg/m2
- The American Society of Anaesthesiologists (ASA) physical status class II III
- Patients who will undergo an elective laparoscopic sleeve gastrectomy (LSG)
Exclusion
- refusal to participate
- allergy to the study drugs
- chronic kidney disease (creatinine\>150 μmol/L)
- mental illness
- liver, respiratory or oncological disease,
- cardiac dysfunction (ejection fraction \<40%),
- uncontrolled hypertension,
- preoperative analgesic use,
- chronic pain,
- history of alcohol or drug addiction
Key Trial Info
Start Date :
April 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04836819
Start Date
April 8 2021
End Date
July 1 2021
Last Update
July 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ondokuz Mayis University
Samsun, Atakum, Turkey (Türkiye), 55270